Victrex plc announces that Dr Martin Court, Chief Commercial Officer and an Executive Director, has notified the Board of his intention to retire from Victrex, after ten years with the Group. Martin joined Victrex in 2013 as Managing Director, Medical & Emerging Business. He joined the Board in 2015 and was appointed as Chief Commercial Officer in October 2019, to oversee the Medical & Industrial divisions, as well as a number of Group functions, including Marketing, Sales, and Research & Development.

Martin will retire from the Board after the September 2023 Board meeting and will remain with the Company until 31 December 2023, in order to support a smooth transition. The Group plans to double down on the significant growth opportunities across the two divisions, with the creation of two roles covering Martin's existing responsibilities. These roles will sit below Board level and report to Jakob Sigurdsson, Chief Executive.

The two roles will be a Managing Director for Medical, taken by Dr John Devine, who is currently the SBU Director Medical and has been with Invibio and the Victrex Group for over 20 years; and a Managing Director, Sustainable Solutions (Industrial). A recruitment process is currently in progress for the latter role, involving both internal and external candidates.